Drug
Cv9104
Cv9104: highest development phase Phase 2, developed by CureVac. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CureVac
Trials
| Drug | Phase | Indication |
|---|---|---|
| CV9104 NCT02140138 | Phase 2 | Prostate Carcinoma |
| CV9104 NCT01817738 | Phase 1/2 | Prostate Cancer |
Latest
No recent events.
Follow Cv9104 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.